New directions in the treatment of Gaucher disease.
Futerman
Anthony H
AH
Department of Biological Chemistry, Weizmann Institute of Science, Rehovot 76100, Israel. tony.futerman@weizmann.ac.il
Sussman
Joel L
JL
Horowitz
Mia
M
Silman
Israel
I
Zimran
Ari
A
D000818:Animals; D005776:Gaucher Disease / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D005962:Glucosylceramidase / Q000737:chemistry / Q000627:therapeutic use; D006801:Humans; D001617:beta-Glucosidase / Q000737:chemistry / Q000627:therapeutic use*
D001617:beta-Glucosidase; D005962:Glucosylceramidase; C090568:imiglucerase